M&As this week: BioTelemetry, Dentium, Codman & Shurtleff

12 April 2017 (Last Updated April 12th, 2017 18:30)

BioTelemetry Inc has announced plans to acquire Swiss healthcare technology and solution company, LifeWatch AG, for CHF260m ($257.6m).

BioTelemetry Inc has announced plans to acquire Swiss healthcare technology and solution company, LifeWatch AG, for CHF260m ($257.6m).

Formerly known as CardioNet Inc, BioTelemetry is a wireless medical technology company based in the US.

The acquisition will enable the company to enhance its remote patient monitoring platform.

Korean medical device company Dentium Co Ltd has announced plans to acquire 96% stake in a medical device company Dentium BMS, based in Iran, for KRW1,360m ($1.16m).

"Korean medical device company Dentium Co, Ltd has announced plans to acquire 96% stake in a medical device company Dentium BMS, based in Iran, for KRW1,360m ($1.16m)."

Codman & Shurtleff Inc (Codman Neuro) has acquired Neuravi Ltd through its subsidiary, DePuy Ireland Unlimited Company.

Codman & Shurtleff is a neurosurgery and neurovascular company based in the US, while Neuravi is an Ireland-based developer of innovative devices for acute stroke treatment.